Back
Corporate News
Natco Pharma’s board will convene August 14 to review financial results and dividend prospects
06-Aug-2026, 05:52
Natco Pharma Limited will hold a board meeting on August 14, 2026, to consider the unaudited financial results for the quarter ended June 30, 2026, and a potential interim dividend for the financial year ending 2026-27; trading window for company insiders will be closed from August 7, 2026, to August 16, 2026, and will reopen on August 17, 2026.
Natco Pharma Limited will hold a board meeting on August 14, 2026, to consider the unaudited financial results for the quarter ended June 30, 2026, and a potential interim dividend for the financial year ending 2026-27; trading window for company insiders will be closed from August 7, 2026, to August 16, 2026, and will reopen on August 17, 2026.